Cold Plasma Market to Attain Worth of USD 6.4 Billion by 2031 | SkyQuest Technology

Westford, USA, Oct. 17, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Cold Plasma Market will reach a value of USD 6.4 Billion by 2031, with a CAGR of 15% during the forecast period (2024-2031). This growth is attributed to general development in the health sector, hence giving birth to new demands for high […]

AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024

Research Triangle Park, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) — Two oral presentations and nine poster presentations will highlight exciting progress in AskBio’s clinical and pre-clinical pipeline and advancements in the company’s manufacturing technologies Alongside recent clinical program milestones, presentations demonstrate AskBio’s commitment to advancing end-to-end capabilities and goal of delivering breakthrough therapies Asklepios BioPharmaceutical,

Veriff named a category leader in the Chartis RiskTech Quadrant for Enterprise Fraud Solutions

New York, Oct. 17, 2024 (GLOBE NEWSWIRE) — Veriff, a leading identity verification and authentication platform, is proud to be named a Category Leader by Chartis in its RiskTech Quadrant for Enterprise Fraud Solutions, and Best in Class Capabilities: Application Fraud and Identity Risk, in RiskTech Quadrant for Enterprise Fraud Solutions for 2024. “We are

Global Molded Pulp Packaging Market to Reach USD 6,067.47 Million by 2032 | Eco-Friendly Solutions in Packaging Industry

Gondia, India, Oct. 17, 2024 (GLOBE NEWSWIRE) — Latest research report published by IMIR Market Research, the market is majorly driven by rising demand for sustainable packaging solutions. Global Molded Pulp Packaging Market Size, Share & Trends Analysis Report by Molded Type (Thick Wall, Transfer Molded, Thermoformed Fiber, Processed Pulp), by Source (Wood pulp, Non

Fitness Equipment Market to Surpass CAGR of 4% by 2031 | SkyQuest Technology

Westford USA, Oct. 17, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Fitness Equipment Market will reach a value of USD 21.35 Billion by 2031, with a CAGR of 4% during the forecast period (2024-2031). Sales of fitness equipment have risen significantly across the globe due to several pivotal reasons. The enhanced health awareness

American Rebel Holdings, Inc. Regains Compliance with NASDAQ Minimum Bid Price Requirement

Nashville, TN, Oct. 17, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), America’s Patriotic Brand (www.americanrebel.com) and the creator of American Rebel Beer (www.americanrebelbeer.com), and manufacturer and marketer of branded safes (www.championsafe.com), personal security and self-defense products and apparel, announced today that on October 16, 2024, it received

ASP Isotopes Inc. Enriches Ytterbium-176 During Commissioning Phase of First Quantum Enrichment Facility and Expects to Offer Highly Enriched Ytterbium-176 for Commercial Sale in 2025

– The Company has accelerated the commissioning phase of its first Quantum Enrichment plant and produced the first semi-finished material of enriched Ytterbium-176. – Commissioning phase was initially anticipated to take 3-6 months, but the Company produced enriched Ytterbium-176 during the first 6 weeks. – The Company expects to be able to achieve a 99.75%

Global Surgical Robots Market to Develop at a Stellar 13.4% CAGR through 2031 | SkyQuest Technology

Westford, USA, Oct. 17, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Surgical Robots Market will attain a value of USD 32.33 billion by 2031, with a CAGR of 13.4% over the forecast period (2024-2031). Advancements in robotic technologies and growing penetration of digital technologies in the healthcare industry are forecasted to primarily bolster the

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

-Transenteric delivery of incretin triagonist GLP-1, GIP, glucagon receptors mimicking the RaniPill route of administration elicits rapid weight loss and bioavailability comparable to subcutaneous injection – – New pharmacokinetic data provides further evidence of the RaniPill platform’s potential to enable oral delivery of multiple obesity treatments – – Phase 1 study for RT-114, an oral

Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints

– Topline results from Phase 2a study – Nearly 60% of all patients treated with gemlapodect and 88% of patients completing the study at the target clinical dose range were responders based on the primary efficacy assessment The Yale Global Tics Severity Scale Total Tic Score (YGTSS-TTS) showed a statistically significant improvement of -7.8 points

Scroll to Top